Artificial Intelligence in Clinical Development to Improve Public Health

General Information

Held at the MIT Media Lab in Cambridge, MA, this event will bring together select leaders and innovators from academia, industry, and government. Our objectives include:

  • Developing a sustainable model to bridge the gap between AI and data science experts and the life sciences community
  • Addressing current and near-term AI, machine learning, and neural network capabilities as they pertain to drug development
  • Identifying new AI inventions and data structures that can solve key drug development challenges
  • Identifying collaborations around use cases for existing AI to solve high-impact drug development challenges
  • Discussing roadblocks limiting the full potential of AI in drug development

The morning will be a forum with presentations on these various topics. The afternoon will include a workshop facilitated by The Boston Consulting Group where speakers and guests can brainstorm.


Nicholas Schork, Ph.D. 
Distinguished Professor of Quantitative Medicine at the Translational Genomics Research Institute (TGen), Director of Human Biology at the J. Craig Venter Institute, and Adjunct Professor of Psychiatry and Biostatistics at the University of California, San Diego.

Sean Khozin, M.D.
Acting Associate Director at FDA’s Oncology Center of Excellence and the founder of Information Exchange and Data Transformation (INFORMED)

Jianying Hu, Ph.D., IEEE Fellow, DRSM
Global Science Leader, AI for Healthcare, Program Director, Center for Computational Health, IBM Research AI

Gustavo A. Stolovitzky, Ph.D.
Adjunct Professor, Genetics and Genomics Sciences, Icahn School of Medicine at Mt. Sinai
Program Director, IBM Translational Systems Biology and Nanobiotechnology

Iyan Rahwan
Associate Professor, MIT Media Lab

Pratik Shah
Principle Investigator, Media Arts and Sciences/Co-PI, Camera Culture Group

Gaurav Singal, M.D.
Vice President, Data Strategy & Product Development, Foundation Medicine

Amy Abernethy, M.D., Ph.D
Chief Medical Officer, Chief Scientific Officer & Senior Vice President, Oncology, Flatiron

Michael Ringel, Ph.D
Senior Partner and Managing Director, BCG

Please see below for information regarding hotel bookings and the agenda.


Overview Session for MIT Media Lab Community, Media Lab Members, and Guests

8:30 Welcome & Objectives for Workshop by Pratik Shah (MIT Media Lab)

8:45 Why Now? Background to meeting and need for change by Francis Kendall and Joling Mew (Roche)

9:00 Keynote - Proving the Case for AI In Drug Development and Health Care: Issues and Strategies by Nicholas J. Schork (TGen, JCVI and UCSD)

9:30 AI and Potential Uses in Clinical Development by Pratik Shah (MIT Media Lab)

9:50 Pharma Perspective on Use of AI by Jason Laramie (Novartis)

10:10 Regulatory Perspective on Use of AI by Sean Khozin (FDA)

10:30 BREAK

10:45 Tech Industry Perspective on Use of AI in Clinical Development by Jianying Hu and Gustavo Stolovitzky (IBM)

11:25 AI & Ethics by Iyad Rahwan (MIT)

11:45 Changes needed for an effective Clinical Development Ecosystem by Gaurav Singal (FMI) and Amy Abernethy (Flatiron)

12:25 Panel Q&A

12:55 Closing


Think Tank Session for MIT Media Lab Members and VIP guests

13:45 Opportunities and Hurdles for AI in Clinical Development by Facilitators from  BCG: Ryan Goosen, Ulrik Schulze, and Michael Ringel

14:45 Readouts and Next Steps by Facilitators from  BCG: Ryan Goosen, Ulrik Schulze, and Michael Ringel

15:15 BREAK


Hotel Room Block Info

Marriott | 50 Broadway, Cambridge, MA 02142
(617) 494-6600
Rate: $285 per night, plus taxes
Deadline: Monday, September 18, 2017, (the “Cut-Off Date”).
Please reference the Drug Development Workshop 

More Events